Primary study · included by 3 reviews

Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.

Sano 2018 · Sano Yoshie, Kogashiwa Yasunao, Araki Ryuichiro, et al. · Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2018

Included by

Prognostic Significance of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Tumor-Associated Neutrophils in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Sano 2018 · Table S3

The review does not say which of its outcomes this study informs.

Prognostic value of NLR versus PLR and LMR in patients with oral squamous cell carcinoma: a meta-analysis.

Non-Cochrane · prognostic · 2026 · cited as Sano 2018 · Table 1; reference list

The review does not say which of its outcomes this study informs.

Cyclooxygenase-2 (COX-2) as a Potential Prognostic Marker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Sano 2017 · Figure 2

Outcome this study informs	Pooled effect	Evidence	Certainty
Progression-free survival High COX-2 expression (immunohistochemistry) vs Low COX-2 expression	HR 1.86 [1.21, 2.87]	3 studies	GRADE not reported
Overall survival High COX-2 expression (immunohistochemistry) vs Low COX-2 expression	HR 1.49 [1.06, 2.1]	8 studies	GRADE not reported

3 including reviews in total.